Abstract
BackgroundTofacitinib is an oral Janus kinase inhibitor. The minimally important changes (MICs) for the SPondyloArthritis Research Consortium of Canada (SPARCC) MRI sacroiliac joint (SIJ) and spine scores based on agreement...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have